Page last updated: 2024-08-25

5-fluoropyrimidine and Metastase

5-fluoropyrimidine has been researched along with Metastase in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ng, S; O'bichere, A; Platell, C; Tebbutt, N	1
Jang, J; Kang, SY; Kim, KM; Lee, J; MacConaill, L; Maeng, CH; Palescandolo, E; Park, HY; Park, SH; Shim, YM; van Hummelen, P	1

Trials

1 trial(s) available for 5-fluoropyrimidine and Metastase

Article	Year
High-throughput genotyping in metastatic esophageal squamous cell carcinoma identifies phosphoinositide-3-kinase and BRAF mutations. PloS one, 2012, Volume: 7, Issue:8 Topics: Adaptor Proteins, Signal Transducing; Adult; Aged; Amino Acid Substitution; Carcinoma, Squamous Cell; Class I Phosphatidylinositol 3-Kinases; Disease-Free Survival; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Mutation, Missense; MutL Protein Homolog 1; Neoplasm Metastasis; Nuclear Proteins; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins B-raf; Pyrimidines; Survival Rate; Tumor Suppressor Protein p53	2012

Article

Year

High-throughput genotyping in metastatic esophageal squamous cell carcinoma identifies phosphoinositide-3-kinase and BRAF mutations.

PloS one, 2012, Volume: 7, Issue:8

Topics: Adaptor Proteins, Signal Transducing; Adult; Aged; Amino Acid Substitution; Carcinoma, Squamous Cell; Class I Phosphatidylinositol 3-Kinases; Disease-Free Survival; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Mutation, Missense; MutL Protein Homolog 1; Neoplasm Metastasis; Nuclear Proteins; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins B-raf; Pyrimidines; Survival Rate; Tumor Suppressor Protein p53

2012

Other Studies

1 other study(ies) available for 5-fluoropyrimidine and Metastase

Article	Year
Changing management and survival in patients with stage IV colorectal cancer. Diseases of the colon and rectum, 2011, Volume: 54, Issue:2 Topics: Adenocarcinoma; Aged; Anastomosis, Surgical; Antineoplastic Agents; Australia; Camptothecin; Capecitabine; Chemotherapy, Adjuvant; Cohort Studies; Colorectal Neoplasms; Colostomy; Deoxycytidine; Female; Fluorouracil; Humans; Irinotecan; Male; Multivariate Analysis; Neoplasm Metastasis; Organoplatinum Compounds; Oxaliplatin; Palliative Care; Proportional Hazards Models; Pyrimidines; Radiotherapy, Adjuvant; Survival Rate	2011

Article

Year

Changing management and survival in patients with stage IV colorectal cancer.

Diseases of the colon and rectum, 2011, Volume: 54, Issue:2

Topics: Adenocarcinoma; Aged; Anastomosis, Surgical; Antineoplastic Agents; Australia; Camptothecin; Capecitabine; Chemotherapy, Adjuvant; Cohort Studies; Colorectal Neoplasms; Colostomy; Deoxycytidine; Female; Fluorouracil; Humans; Irinotecan; Male; Multivariate Analysis; Neoplasm Metastasis; Organoplatinum Compounds; Oxaliplatin; Palliative Care; Proportional Hazards Models; Pyrimidines; Radiotherapy, Adjuvant; Survival Rate

2011